Target intelligence / Profile preview

Helicobacter pylori proteins and surface structures (H. pylori targets)

Target
H. pylori targets
Molecular classification
Enzyme, Other
01

Overview

Helicobacter pylori is a Gram-negative, spiral-shaped bacterium that colonizes the human stomach, leading to chronic inflammation and significant gastrointestinal diseases such as peptic ulcers and gastric adenocarcinoma (StatPearls, 2023). The target "Multiple H. pylori proteins and surface structures" refers to a collective group of bacterial components essential for its survival in the acidic gastric environment and its ability to cause disease. Key components include the enzyme urease, which neutralizes stomach acid by producing ammonia, and virulence factors such as Cytotoxin-associated gene A (CagA) and Vacuolating cytotoxin A (VacA) that disrupt host cellular processes and induce apoptosis (Amieva & Peek, 2016). Surface structures like flagella enable motility through the mucus layer, while adhesins such as Blood group antigen-binding adhesin (BabA) facilitate attachment to gastric epithelial cells (NCBI, 2022). Current therapeutic strategies utilize a combination of antibiotics, such as amoxicillin and clarithromycin, which target bacterial cell wall synthesis and protein synthesis respectively, often in conjunction with acid-suppressing agents (Chey et al., 2017). This multi-target approach is critical for effective eradication, although rising antibiotic resistance remains a major therapeutic challenge (Malfertheiner et al., 2022).

Other names
Helicobacter pylori antigensH. pylori virulence factorsH. pylori surface proteinsH. pylori proteome
02

Mechanism of action

Inhibition of bacterial cell wall synthesis, inhibition of protein synthesis via 50S or 30S ribosomal subunits, inhibition of DNA gyrase, and disruption of DNA helical structure.

03

Biological functions

Immune responseCell deathOther
04

Disease associations

InfectionCancerInflammation
05

Safety considerations

Development of multidrug-resistant strainsGastrointestinal dysbiosisRisk of Clostridioides difficile-associated diarrheaAllergic reactions to beta-lactams
06

Interacting drugs

Amoxicillin

7 more in the full profile.

07

Biomarkers

13C-Urea breath testH. pylori stool antigen testRapid urease testAnti-H. pylori IgG serology

Beyond the preview

Go deeper on Helicobacter pylori proteins and surface structures (H. pylori targets).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Helicobacter pylori proteins and surface structures (H. pylori targets).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call